Valuation Finch Therapeutics Group, Inc.

Stocks

Delayed OTC Markets 20:12:40 23/09/2026 BST			5-day change	1st Jan Change
10.35 ^USD	-1.43%		0.00%	-23.26%

09-03	Second Modified First Amended Combined Joint Liquidation Plan and Disclosure Stataement Approved for Finch Therapeutics Group, Inc.	CI
07-24	First Amended Disclosure Statement Conditionally Approved on an Interim Basis for Finch Therapeutics Group, Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	473.4	22.99	5.797
Change	-	-95.14%	-74.79%
Enterprise Value (EV) ¹	345.9	4.311	10.8
Change	-	-98.75%	150.5%
P/E	-6.72x	-0.2x	-0.08x
PBR	2.34x	0.24x	0.25x
PEG	0.1x	-0x	0x
Capitalization / Revenue	25.5x	26.7x	54.2x
EV / Revenue	18.7x	5.01x	101x
EV / EBITDA	-6x	-0.05x	-0.33x
EV / EBIT	-5.77x	-0.05x	-0.32x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-44.51	-72.12	-46.59
Distribution rate	-	-	-
Net sales ¹	18.53	0.861	0.107
EBITDA ¹	-57.68	-89.61	-32.48
EBIT ¹	-59.98	-95.12	-34
Net income ¹	-58.16	-114.6	-74.75
Net Debt ¹	-127.4	-18.68	5.002
Reference price ²	299.10	14.40	3.61
Nbr of stocks (in thousands)	1,583	1,597	1,606
Announcement Date	31/03/22	23/03/23	25/03/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FINCH THERAPEUTICS GROUP, INC.	-	-	-	-	16.62M
LONZA GROUP AG	32.83x	5.9x	17.66x	0.99%	47.56B
IQVIA HOLDINGS INC.	34.5x	3.33x	14.35x	-.--%	44.09B
BEONE MEDICINES AG	47.81x	5.54x	30.34x	-.--%	41.5B
REVOLUTION MEDICINES, INC.	-19.6x	208.56x	-21.12x	-.--%	40.88B
CELLTRION, INC.	26.85x	7.74x	19.93x	0.42%	29.67B
MEDPACE HOLDINGS, INC.	35.1x	5.76x	26.17x	-.--%	17.23B
EUROFINS SCIENTIFIC SE	25.39x	2.19x	9.48x	1.05%	15.06B
TEMPUS AI, INC.	-55x	9.03x	220.54x	-.--%	13.82B
Average	15.98x	31.01x	39.67x	0.31%	27.76B
Weighted average by Cap.	21.17x	38.71x	24.42x	0.3%